Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Home Print this page Email this page
Users Online: 36

Year : 2010  |  Volume : 7  |  Issue : 1  |  Page : 16-19

Management of hypertension in thyroid disease: Results from the IMPERIAL study-1

1 Bharti Hospital & B.R.I.D.E, Karnal, India
2 Excel Care Hospitals, Guwahati, India
3 G.R. Medical College, Gwalior, India
4 G.S Medical College &K.E.M Hospital, Mumbai, India
5 M.M.I.M.S.R, Mullana, Ambala, India
6 USV Ltd, Mumbai, India

Correspondence Address:
S Kalra
Bharti Hospital & B.R.I.D.E, Karnal
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

The IMPERIAL (Indian Medical Practitioners Expressions Regarding Drug Intervention In All Aspects of MetaboLic Syndrome) study, which assessed Indian physicians' prescribing habits related to metabolic syndrome, also assessed their preferred management strategies in hypertension associated with thyroid dysfunction. This paper reviews the results related to thyroid disease, obtained from the IMPERIAL study. There is a clear consensus for the use of beta-blockers as first line antihypertensive therapy in patients with hypothyroidism. For hypothyroid patients with hypertension, ACEI, ARB and diuretics are recommended as first - line therapy by one third of the physicians each. It is hoped that these results forms the basis for a debate, and final consensus, on the management of hypertension in thyroid disorders.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded323    
    Comments [Add]    

Recommend this journal